Qualified Health Claims Research Supports Moratorium On Claims – CSPI
This article was originally published in The Tan Sheet
Executive Summary
"FDA should rescind its approval of all qualified health claims and impose a moratorium on the approval of additional qualified claims" that do not meet significant scientific agreement standards, the Center for Science in the Public Interest argued following a presentation of consumer research on health claims
You may also be interested in...
OMB Grants CFSAN Green Light For Qualified Health Claim Study
CFSAN is refining its approach to report card schemes as well as other ways of communicating qualified health claims (QHCs) in a proposed study approved by OMB Nov. 29
OMB Grants CFSAN Green Light For Qualified Health Claim Study
CFSAN is refining its approach to report card schemes as well as other ways of communicating qualified health claims (QHCs) in a proposed study approved by OMB Nov. 29
OMB Grants CFSAN Green Light For Qualified Health Claim Study
CFSAN is refining its approach to report card schemes as well as other ways of communicating qualified health claims (QHCs) in a proposed study approved by OMB Nov. 29